Reversible exacerbation of parkinsonism during epirubicin–cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson’s disease
- DOI
- 10.1007/s10072-026-09361-1
- Published
- 2026-09-11
- Container
- Neurological Sciences
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10072-026-09361-1,
title = {Reversible exacerbation of parkinsonism during epirubicin–cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson’s disease},
author = {Nobuaki Wakamatsu and Shoko Norimura and Misako Nakagawa and Akihiro Hirao and Mao Mukai and Yoshiteru Urai and Tatsushi Toda and Shoji Tsuji and Jun Mitsui},
year = {2026},
journal = {Neurological Sciences},
doi = {10.1007/s10072-026-09361-1},
url = {https://doi.org/10.1007/s10072-026-09361-1}
}RIS
TY - JOUR TI - Reversible exacerbation of parkinsonism during epirubicin–cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson’s disease AU - Nobuaki Wakamatsu AU - Shoko Norimura AU - Misako Nakagawa AU - Akihiro Hirao AU - Mao Mukai AU - Yoshiteru Urai AU - Tatsushi Toda AU - Shoji Tsuji AU - Jun Mitsui PY - 2026 JO - Neurological Sciences DO - 10.1007/s10072-026-09361-1 UR - https://doi.org/10.1007/s10072-026-09361-1 ER -
APA
Wakamatsu, N., Norimura, S., Nakagawa, M., Hirao, A., Mukai, M., Urai, Y., Toda, T., Tsuji, S., & Mitsui, J. (2026). Reversible exacerbation of parkinsonism during epirubicin–cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson’s disease. Neurological Sciences. https://doi.org/10.1007/s10072-026-09361-1
Source records
- crossref · retrieved 2026-09-26T18:21:15.596Z